Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in
Advertisement

Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Avi Kapoor 1 month ago

MarketsTrading IdeasPre-Market OutlookMoversNews

U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and other stocks also dropped in premarket trading.

U.S. stock futures were mixed this morning, with the Dow futures falling around 200 points on Thursday.

Shares of Progress Software Corp (NASDAQ:PRGS) fell sharply in pre-market trading after the company reported third-quarter financial results.

Progress Software reported fiscal third-quarter revenue of $246 million, down 2% year over year, while non-GAAP EPS rose 13% to $1.69 and ARR increased 1% to $873 million.

Progress Software shares dipped 2.3% to $39.05 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Corteva Inc (NYSE:CTVA) tumbled 56.6% to $33.89 in pre-market trading.
  • Nft Ltd (NYSE:MI) fell 54.6% to $0.98 in pre-market trading after the company announced a $36 million offering of 80 million shares at $0.45 per share.
  • Vivakor inc (NASDAQ:VIVK) fell 20.8% to $0.40 in pre-market trading after the company announced a 1-for-15 reverse stock split of its issued and outstanding common stock.
  • Lion Group Holding Ltd – ADR (NASDAQ:LGHL) fell 15.4% to $4.81 in pre-market trading after jumping over 25% on Wednesday. Lion Group recently announced a strategic reallocation of a portion of its digital-asset treasury.
  • Inventiva SA – ADR (NASDAQ:IVA) fell 8.1% to $3.39 in pre-market trading after gaining 12% on Wednesday.
  • SGHC Ltd (NYSE:SGHC) fell 6.4% to $10.63 in pre-market trading.
  • Waterdrop Inc – ADR (NYSE:WDH) declined 5.8% to $0.96 in pre-market trading.
  • Paysign Inc (NASDAQ:PAYS) fell 5% to $12.81 in pre-market trading.
  • Liquidia Corp (NASDAQ:LQDA) dipped 4.2% to $28.99 in pre-market trading. On Wednesday, a federal court in Delaware ruled that two claims of a patent asserted by United Therapeutics (NASDAQ:UTHR) are valid and infringed by Liquidia, the company said in a press release. The litigation concerns Yutrepia (treprostinil) inhalation powder, Liquidia’s lead product.
  • Pacific Biosciences of California Inc (NASDAQ:PACB) fell 3.4% to $2.29 in pre-market trading.

Photo via Shutterstock

Read the original

Advertisement